Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Lung (Non-Small Cell)
Study Phase
Phase 3
Study Completion Date
April 2012
NCT00409188Uploaded 10-21-2015
Available for Download
PDS UID: LungNo_MerckKG_2007_145
A Multi-center Phase III Randomized, Double-blind Placebo-controlled Study of the Cancer Vaccine Stimuvax® (L-BLP25 or BLP25 Liposome Vaccine) in Non-small Cell Lung Cancer (NSCLC) Subjects With Unresectable Stage III Disease.
PDS UID: LungNo_Multipl_2018_231Go to Study
Enhancing the Analytic Capacity of LungNo_MerckKG_2007_145 using a Statistical Linkage Method to Append Socioeconomic and Health Care Access Variables from the Medical Expenditure Panel Survey
Files:
PROTOCOLEMR63325-001_start_v07_Redacted Clinical Study Protocol.pdf
CRFEMR63325-001_START_SAS annotated eCRF_.pdf.pdf
DATA DICTIONARYData Dictionary.pdf
DATA (COMPARATOR ARM)emr63325-001_START_Raw Data.zip